U.S. market Closed. Opens in 10 hours 13 minutes

MRSN | Mersana Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue36.85M26.58M43.00K828.00K42.12M10.59M17.55M25.17M10.36M
Cost of Revenue1.52M927.00K132.01M67.04M55.04MN/AN/AN/AN/A
Gross Profit35.34M25.65M-131.97M-66.21M-12.92M10.59MN/AN/AN/A
Operating Expenses206.29M230.35M168.90M88.94M72.32M76.25M57.16MN/AN/A
Selling, General & Admin58.03M56.96M36.89M21.90M17.28M16.33M10.46M6.98M5.35M
Research & Development148.27M173.38M132.01M67.04M55.04M59.91M46.70M32.01M21.35M
Other Operating Expenses8.71M-445.00K-1.20MN/AN/A1.40MN/AN/AN/A
Operating Income-170.96M-204.69M-169.71M-87.69M-29.22M-65.66M-39.62M-13.82M-16.34M
Other Expenses / Income-713.00K482.00K-347.00K-359.00K1.01M1.40M910.00K121.00K-87.00K
Before Tax Income-171.67M-204.21M-170.06M-88.05M-28.21M-64.26M-38.71M-13.70M-16.43M
Income Tax Expenses1.35M3.33M-855.00K359.00K-1.01M1.40MN/AN/AN/A
Net Income-171.67M-207.54M-169.21M-88.40M-27.20M-64.26M-38.71M-13.70M-16.43M
Interest Expenses4.07M3.33M1.27M359.00K234.00KN/AN/AN/AN/A
Basic Shares Outstanding116.11M93.65M70.58M61.49M43.40M23.03M12.02M13.59M17.49M
Diluted Shares Outstanding116.11M93.65M70.58M61.49M43.49M23.03M12.02M13.59M17.49M
EBITDA-169.44M-203.77M-168.86M-86.68M-27.97M-65.66M-37.78M-13.04M-16.13M
EBITDA Margin-459.75%-766.59%-392,693.02%-10,468.12%-66.41%-619.74%-215.33%-51.83%-155.72%
EBIT-166.25M-200.88M-168.79M-87.69M-27.97M-62.86M-38.71M-13.70M-16.43M
EBIT Margin-451.09%-755.74%-392,541.86%-10,590.10%-66.41%-593.35%-220.62%-54.43%-158.59%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙